Curated Wealth Partners LLC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1781284
EL SEGUNDO, CA
Position in SUPN
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$1,830,260
New position
Shares Held
39,352
first reported quarter
Ownership
0.068%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#4
of 29 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 97%
Shared 0%
None 3%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Curated Wealth Partners LLC holds $39,127,348 across 6 Drug Manufacturers - Specialty & Generic names. SUPN ranks #3 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
403,819 | $29,018,433 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
47,715 | $8,041,886 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
39,352 | $1,830,260 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
20,000 | $200,000 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
521 | $24,627 | |
| 6 | ANIK |
Anika Therapeutics, Inc.
|
830 | $12,142 |
All Filings in SUPN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,830,260 | 39,352 | Shares | Sole | 2026-07-13 | |
| No filing history on record for this holder in this stock. | ||||||